Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognitionCrina Paduraru, Jelena S Bezbradica, Amit Kunte, et al.Journal of Lipid Research|October 1, 2013
1-O-acylceramides are natural components of human and mouse epidermisMariona Rabionet, Aline Bayerle, Christian Marsching, et al.Kidney International|January 10, 2014
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry diseaseLiming Shu, Anuradha Vivekanandan-Giri, Subramaniam Pennathur, et al.Stroke|March 4, 2006
Alpha-galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V Leiden mutationYuechun Shen, Peter F Bodary, Fernando B Vargas, et al.Journal of the American Society of Nephrology : JASN|January 23, 2003
Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosisDaniel T Eitzman, Peter F Bodary, Yuechun Shen, et al.The Journal of Biological Chemistry|May 19, 2005
Ceramide 1-phosphate, a mediator of phagocytosisVania Hinkovska-Galcheva, Laurence A Boxer, Andrei Kindzelskii, et al.Journal of Innate Immunity|February 18, 2010
Calcium-independent phospholipase A2 beta is dispensable in inflammasome activation and its inhibition by bromoenol lactoneLuigi Franchi, Grace Chen, Noemi Marina-Garcia, et al.FEBS Letters|August 7, 2002
Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growthSteven B Levery, Michelle Momany, Rebecca Lindsey, et al.Cell Chemical Biology|September 24, 2016
Lysosomal Lipases PLRP2 and LPLA2 Process Mycobacterial Multi-acylated Lipids and Generate T Cell Stimulatory AntigensMartine Gilleron, Marco Lepore, Emilie Layre, et al.Journal of Lipid Research|November 8, 2011
Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brainScott D Larsen, Michael W Wilson, Akira Abe, et al.Pageof 10